| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/21/2001 | WO2001043696A2 Implant device for implanting cell culture |
| 06/21/2001 | WO2001043660A2 Porous three dimensional structure |
| 06/21/2001 | WO2001043545A2 Fluid insecticidal formulations for dermal treatment of parasitic insect larvae |
| 06/21/2001 | WO2001043528A2 Devices and methods in intracerebrospinal delivery of morphine-6-glucuronide |
| 06/21/2001 | WO2001017527A9 Preventive and therapeutic agents for eye diseases |
| 06/21/2001 | WO2001014393A3 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 06/21/2001 | WO2001013892A3 Large porous particles by spray-drying |
| 06/21/2001 | WO2001010411A3 Implantable active ingredient depot |
| 06/21/2001 | WO2001008505A9 Methods for suppressing appetite and enhancing exercise and recovery |
| 06/21/2001 | WO2001005371A8 Method for modifying physical and chemical and/or biological properties of a material |
| 06/21/2001 | WO2000075281A3 Supercritical fluid-assisted nebulization and bubble drying |
| 06/21/2001 | WO2000066087A3 Emulsion-based processes for making microparticles |
| 06/21/2001 | WO2000061191A9 Heat stable coated colloidal iron oxides |
| 06/21/2001 | WO2000042986A8 Artificial lacrimal fluid in gel form |
| 06/21/2001 | WO2000039095B1 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 06/21/2001 | WO2000013476A9 A bubble drop and method of making same |
| 06/21/2001 | WO1997042975A9 Chitosan related compositions for delivery of nucleic acids into a cell |
| 06/21/2001 | US20010004644 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| 06/21/2001 | US20010004643 Pharmaceutical composition with sotalol combination and their use in treatment of cardiac ailments |
| 06/21/2001 | US20010004642 Amino fruit acid composition and method for the treatment of skin |
| 06/21/2001 | US20010004637 Includes at least one of a water soluble antioxidant, a fat soluble antioxidant, a synergist, a sugar and a surfactant |
| 06/21/2001 | US20010004459 Composition with sustained release of active principle, capable of forming a microemulsion |
| 06/21/2001 | US20010004458 Rapidly disintegrating pellets |
| 06/21/2001 | DE19961334A1 Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere Injection method for neutral and acid group-containing (meth) acrylate copolymers |
| 06/21/2001 | DE19960775A1 Dermal applizierbare insektizide Flüssigformulierungen zur Bekämpfung von parasitierenden Insektenlarven Applied dermally insecticidal liquid formulations for controlling parasitic insect larvae |
| 06/21/2001 | DE19960494A1 Vorrichtung und Verfahren zum Herstellen von festen wirkstoffhaltigen Formen Apparatus and method for producing solid forms containing active substance |
| 06/21/2001 | DE19959419A1 Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung Stable pharmaceutical formulations comprising a benzimidazole and process for their preparation |
| 06/21/2001 | DE19959036A1 Verfahren zur Herstellung von Pulverprodukten A process for the preparation of powder products |
| 06/21/2001 | DE19956486A1 Mehrschichtige Zubereitung zur gesteuerten, pulsartigen Abgabe von Wirkstoffen Multi-layer preparation for controlled, pulsatile delivery of active ingredients |
| 06/21/2001 | CA2397601A1 Novel processes for making- and a new crystalline form of- leflunomide |
| 06/21/2001 | CA2396543A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation |
| 06/21/2001 | CA2395555A1 Processes for preparing clarithromycin polymorphs and novel polymorph iv |
| 06/21/2001 | CA2395474A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | CA2395289A1 Transdermal administration of phenylpropanolamine |
| 06/21/2001 | CA2394968A1 Dosage forms having a barrier layer to laser ablation |
| 06/21/2001 | CA2394613A1 Method for localized administration of fibrinolytic metalloproteinases |
| 06/21/2001 | CA2394588A1 Controlled release kcl tablet formulations |
| 06/21/2001 | CA2394569A1 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 06/21/2001 | CA2394416A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | CA2394353A1 Electrostatic application of powder material to solid dosage forms |
| 06/21/2001 | CA2394288A1 Glyceride oil based coating waxes |
| 06/21/2001 | CA2394213A1 Polypeptide compositions with improved stability |
| 06/21/2001 | CA2394211A1 Stabilizers for sodium l-ascorbate-2-phosphate |
| 06/21/2001 | CA2394077A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | CA2393838A1 Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | CA2393371A1 Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory iga's |
| 06/21/2001 | CA2391957A1 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 06/21/2001 | CA2391950A1 Implant composition containing melengestrol acetate and trenbolone acetate |
| 06/21/2001 | CA2391802A1 Fluid insecticidal formulations for treatment of parasitic insect larvae by dermal application |
| 06/20/2001 | EP1108779A2 Three-dimensional shape and crystal form of polypeptides comprising a sub-domain of calpain |
| 06/20/2001 | EP1108431A1 Gastroresistant multi-unitary pharmaceutical preparations containing piroxicam |
| 06/20/2001 | EP1108429A2 An improved amino acid composition for providing an amino acid supplement or protein substitute, particularly for the treatment and/or management of certain diseases |
| 06/20/2001 | EP1108425A1 New stable multi-unitary pharmaceutical preparations containing substituted benzimidazoles |
| 06/20/2001 | EP1108424A1 Matrix tablet for sustained release of trimetazidine after oral administration |
| 06/20/2001 | EP1108423A1 Powdery pernasal compositions |
| 06/20/2001 | EP1108422A2 Medical product for moisturising and cleansing the nasal mucosa |
| 06/20/2001 | EP1108365A2 Encapsulated long chain alcohols |
| 06/20/2001 | EP1108028A2 Dna cancer vaccine and methods for its use |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 06/20/2001 | EP1107981A2 Ring modified cyclic peptide analogs |
| 06/20/2001 | EP1107862A1 Production of multiphase moulded pieces |
| 06/20/2001 | EP1107823A1 Method for treating a particulate material with a coating substance and device for implementing such a method |
| 06/20/2001 | EP1107812A1 Gelatinous body protection article having a therapeutic additive |
| 06/20/2001 | EP1107802A1 Gels and multilayer surface structures from boronic acid containing polymers |
| 06/20/2001 | EP1107794A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 06/20/2001 | EP1107792A1 Pharmaceutical composition containing calcium valproate with delayed active substance release and method for the production of said composition |
| 06/20/2001 | EP1107791A2 Hydrogel compositions for the controlled release administration of growth factors |
| 06/20/2001 | EP1107783A1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 06/20/2001 | EP1107782A1 Oral vaccine compositions |
| 06/20/2001 | EP1107777A1 Stabilized pharmaceutical composition in lyophilized form |
| 06/20/2001 | EP1107775A1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 06/20/2001 | EP1107772A2 Probiotic, lactic acid-producing bacteria and uses thereof |
| 06/20/2001 | EP1107763A1 Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug |
| 06/20/2001 | EP1107762A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 06/20/2001 | EP1107759A1 Pyridinones for the treatment of sexual dysfunction |
| 06/20/2001 | EP1107750A2 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 06/20/2001 | EP1107749A2 The use of fumaric acid derivatives in transplant medicine |
| 06/20/2001 | EP1107748A2 Methods and compositions employing optically pure s(+) vigabatrin |
| 06/20/2001 | EP1107743A1 Stable spray-dried protein formulations |
| 06/20/2001 | EP1107742A1 Plaster containing a medicament, with three functional layers |
| 06/20/2001 | EP1107741A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 06/20/2001 | EP1107740A1 Timed release tablet comprising naproxen and pseudoephedrine |
| 06/20/2001 | EP1107739A1 Method for producing solid dosing forms |
| 06/20/2001 | EP1107737A1 Microparticles |
| 06/20/2001 | EP1107736A1 Microparticulate composition |
| 06/20/2001 | EP1107735A1 Omeprazole formulation |
| 06/20/2001 | EP1107734A1 Oral liquid mucoadhesive compositions |
| 06/20/2001 | EP1107733A1 Oral liquid mucoadhesive compositions |
| 06/20/2001 | EP1107732A1 Oral liquid mucoadhesive compositions |
| 06/20/2001 | EP1107731A1 Synthetic tear fluid |
| 06/20/2001 | EP1107730A2 Medicated chewing gum delivery system for nicotine |
| 06/20/2001 | EP1107729A1 Electrically controlled transport of charged penetrants across barriers |
| 06/20/2001 | EP1107707A1 Stent coating |
| 06/20/2001 | EP1107702A1 Ultrasonic enhancement of drug injection |
| 06/20/2001 | EP1071485A4 Revascularization apparatus having coaxial channeling and injection means |
| 06/20/2001 | EP0936893B1 Multiple flow path device for oral delivery of discrete units |
| 06/20/2001 | EP0904057B1 Liposome encapsulated amphiphilic drug compositions |
| 06/20/2001 | EP0817621B1 Pharmaceutical composition for transdermic delivery |
| 06/20/2001 | EP0767658A4 Anti-acne cosmetic compositions |